{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T05:43:30Z","timestamp":1693979010639},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00105-019-04484-3","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T09:02:36Z","timestamp":1569574956000},"page":"870-874","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Klassifikation des Plattenepithelkarzinoms der\u00a0Haut"],"prefix":"10.1007","volume":"70","author":[{"given":"Lukas","family":"Kofler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"4484_CR1","unstructured":"S3-Leitlinie Aktinische Keratose und Plattenepithelkarzinom der Haut. AWMF, 2019. \n                    https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/032-022OLk_S3_Aktinische_Keratosen-Plattenepithelkarzinom-PEK_2019-07.pdf\n                    \n                  . Zugegriffen: 23. Juli 2019"},{"key":"4484_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin\u00a0MB, Edge\u00a0S, Greene\u00a0F et\u00a0al (2017) AJCC cancer staging manual, 8.\u00a0Aufl. Springer, Berlin Heidelberg","edition":"8"},{"issue":"Suppl 3","key":"4484_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1468-3083.2012.04520.x","volume":"26","author":"E Archier","year":"2012","unstructured":"Archier\u00a0E, Devaux\u00a0S, Castela\u00a0E et al (2012) Carcinogenic risks of psoralen UV\u2011A therapy and narrowband UV\u2011B therapy in chronic plaque psoriasis: a\u00a0systematic literature review. J\u00a0Eur Acad Dermatol Venereol 26(Suppl 3):22\u201331. \n                    https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04520.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4484_CR4","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/hed.24765","volume":"39","author":"BG Ashford","year":"2017","unstructured":"Ashford\u00a0BG, Clark\u00a0J, Gupta\u00a0R et al (2017) Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: A search for prognostic markers and therapeutic targets. Head Neck 39:1462\u20131469. \n                    https:\/\/doi.org\/10.1002\/hed.24765","journal-title":"Head Neck"},{"key":"4484_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","volume":"9","author":"KD Brantsch","year":"2008","unstructured":"Brantsch\u00a0KD, Meisner\u00a0C, Sch\u00f6nfisch\u00a0B et al (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a\u00a0prospective study. Lancet Oncol 9:713\u2013720. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(08)70178-5","journal-title":"Lancet Oncol"},{"key":"4484_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1610-0387.2012.07896.x","volume":"10","author":"H Breuninger","year":"2012","unstructured":"Breuninger\u00a0H, Brantsch\u00a0K, Eigentler\u00a0T, H\u00e4fner\u00a0H\u2011M (2012) Comparison and evaluation of the current staging of cutaneous carcinomas. J\u00a0Dtsch Dermatol Ges 10:579\u2013586. \n                    https:\/\/doi.org\/10.1111\/j.1610-0387.2012.07896.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"4484_CR7","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2017","unstructured":"Brierley\u00a0JD, Gospodarowicz\u00a0M, Wittekind\u00a0C (2017) TNM classification of malignant tumours, 8.\u00a0Aufl. Wiley-Blackwell, Hoboken","edition":"8"},{"key":"4484_CR8","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/ddg.12466","volume":"12","author":"FC Eberle","year":"2014","unstructured":"Eberle\u00a0FC, Kanyildiz\u00a0M, Schnabl\u00a0SM et\u00a0al (2014) Three dimensional (3D) histology in daily routine: practical implementation and its evaluation. J\u00a0Dtsch Dermatol Ges 12:1028\u20131035. \n                    https:\/\/doi.org\/10.1111\/ddg.12466","journal-title":"J Dtsch Dermatol Ges"},{"key":"4484_CR9","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.jid.2017.06.025","volume":"137","author":"TK Eigentler","year":"2017","unstructured":"Eigentler\u00a0TK, Leiter\u00a0U, H\u00e4fner\u00a0H\u2011M et al (2017) Survival of patients with cutaneous squamous cell carcinoma: results of a\u00a0prospective cohort study. J\u00a0Invest Dermatol 137:2309\u20132315. \n                    https:\/\/doi.org\/10.1016\/j.jid.2017.06.025","journal-title":"J Invest Dermatol"},{"key":"4484_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/(SICI)1096-9098(199602)61:2<124::AID-JSO6>3.0.CO;2-E","volume":"61","author":"A Ero\u011flu","year":"1996","unstructured":"Ero\u011flu\u00a0A, Berbero\u011flu\u00a0U, Berrero\u011flu\u00a0S (1996) Risk factors related to locoregional recurrence in squamous cell carcinoma of the skin. J\u00a0Surg Oncol 61:124\u2013130. https:\/\/doi.org\/10.1002\/(SICI)1096-9098(199602)61:2\u3008124::AID-JSO6\u30093.0.CO;2\u2011E","journal-title":"J Surg Oncol"},{"key":"4484_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jaad.2010.08.033","volume":"64","author":"S Farasat","year":"2011","unstructured":"Farasat\u00a0S, Yu\u00a0SS, Neel\u00a0VA et\u00a0al (2011) A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J\u00a0Am Acad Dermatol 64:1051\u20131059. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2010.08.033","journal-title":"J Am Acad Dermatol"},{"key":"4484_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0140-6736(98)12168-2","volume":"354","author":"A Green","year":"1999","unstructured":"Green\u00a0A, Williams\u00a0G, Neale\u00a0R et al (1999) Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a\u00a0randomised controlled trial. Lancet 354:723\u2013729. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(98)12168-2","journal-title":"Lancet"},{"key":"4484_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.coi.2004.01.009","volume":"16","author":"FT Hakim","year":"2004","unstructured":"Hakim\u00a0FT, Flomerfelt\u00a0FA, Boyiadzis\u00a0M, Gress\u00a0RE (2004) Aging, immunity and cancer. Curr Opin Immunol 16:151\u2013156. \n                    https:\/\/doi.org\/10.1016\/j.coi.2004.01.009","journal-title":"Curr Opin Immunol"},{"key":"4484_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1017\/S0022215100134668","volume":"110","author":"BE Hartley","year":"1996","unstructured":"Hartley\u00a0BE, Searle\u00a0AE, Breach\u00a0NM et\u00a0al (1996) Aggressive cutaneous squamous cell carcinoma of the head and neck in patients with chronic lymphocytic leukaemia. J\u00a0Laryngol Otol 110:694\u2013695","journal-title":"J Laryngol Otol"},{"key":"4484_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.ijom.2011.02.036","volume":"40","author":"H-M H\u00e4fner","year":"2011","unstructured":"H\u00e4fner\u00a0H\u2011M, Breuninger\u00a0H, Moehrle\u00a0M et al (2011) 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome. Int J Oral Maxillofac Surg 40:943\u2013948. \n                    https:\/\/doi.org\/10.1016\/j.ijom.2011.02.036","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4484_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1684\/ejd.2011.1290","volume":"21","author":"W Hoetzenecker","year":"2011","unstructured":"Hoetzenecker\u00a0W, Guenova\u00a0E, B\u00f6ttinger\u00a0TU et\u00a0al (2011) Mapping of specific sentinel node locations for skin cancer of the head. Eur J Dermatol 21:354\u2013358. \n                    https:\/\/doi.org\/10.1684\/ejd.2011.1290","journal-title":"Eur J Dermatol"},{"key":"4484_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1600-0625.2010.01086.x","volume":"19","author":"GFL Hofbauer","year":"2010","unstructured":"Hofbauer\u00a0GFL, Bouwes Bavinck\u00a0JN, Euvrard\u00a0S (2010) Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol 19:473\u2013482. \n                    https:\/\/doi.org\/10.1111\/j.1600-0625.2010.01086.x","journal-title":"Exp Dermatol"},{"key":"4484_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","volume":"149","author":"A Jambusaria-Pahlajani","year":"2013","unstructured":"Jambusaria-Pahlajani\u00a0A, Kanetsky\u00a0PA, Karia\u00a0PS et al (2013) Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a\u00a0proposed alternative tumor staging system. JAMA Dermatol 149:402\u2013410. \n                    https:\/\/doi.org\/10.1001\/jamadermatol.2013.2456","journal-title":"JAMA Dermatol"},{"key":"4484_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","volume":"68","author":"PS Karia","year":"2013","unstructured":"Karia\u00a0PS, Han\u00a0J, Schmults\u00a0CD (2013) Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J\u00a0Am Acad Dermatol 68:957\u2013966. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2012.11.037","journal-title":"J Am Acad Dermatol"},{"key":"4484_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","volume":"32","author":"PS Karia","year":"2014","unstructured":"Karia\u00a0PS, Jambusaria-Pahlajani\u00a0A, Harrington\u00a0DP et al (2014) Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women\u2019s Hospital tumor staging for cutaneous squamous cell carcinoma. J\u00a0Clin Oncol 32:327\u2013334. \n                    https:\/\/doi.org\/10.1200\/JCO.2012.48.5326","journal-title":"J Clin Oncol"},{"key":"4484_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/bjd.13508","volume":"172","author":"JT Krediet","year":"2015","unstructured":"Krediet\u00a0JT, Beyer\u00a0M, Lenz\u00a0K et\u00a0al (2015) Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol 172:1029\u20131036. \n                    https:\/\/doi.org\/10.1111\/bjd.13508","journal-title":"Br J Dermatol"},{"key":"4484_CR22","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.jid.2017.04.020","volume":"137","author":"U Leiter","year":"2017","unstructured":"Leiter\u00a0U, Keim\u00a0U, Eigentler\u00a0T et\u00a0al (2017) Incidence, mortality, and trends of nonmelanoma skin cancer in Germany. J\u00a0Invest Dermatol 137:1860\u20131867. \n                    https:\/\/doi.org\/10.1016\/j.jid.2017.04.020","journal-title":"J Invest Dermatol"},{"key":"4484_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1046\/j.1365-2133.1999.02928.x","volume":"141","author":"B Lindel\u00f6f","year":"1999","unstructured":"Lindel\u00f6f\u00a0B, Sigurgeirsson\u00a0B, Tegner\u00a0E et al (1999) PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 141:108\u2013112","journal-title":"Br J Dermatol"},{"key":"4484_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archderm.1997.03890410031004","volume":"133","author":"TA Maurer","year":"1997","unstructured":"Maurer\u00a0TA, Christian\u00a0KV, Kerschmann\u00a0RL et al (1997) Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Arch Dermatol 133:577\u2013583","journal-title":"Arch Dermatol"},{"key":"4484_CR25","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.jaad.2005.08.055","volume":"53","author":"K Mehrany","year":"2005","unstructured":"Mehrany\u00a0K, Weenig\u00a0RH, Lee\u00a0KK et\u00a0al (2005) Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia. J\u00a0Am Acad Dermatol 53:1067\u20131071. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2005.08.055","journal-title":"J Am Acad Dermatol"},{"key":"4484_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00042728-200501000-00008","volume":"31","author":"K Mehrany","year":"2005","unstructured":"Mehrany\u00a0K, Weenig\u00a0RH, Pittelkow\u00a0MR et\u00a0al (2005) High recurrence rates of squamous cell carcinoma after Mohs\u2019 surgery in patients with chronic lymphocytic leukemia. Dermatol Surg 31:38\u201342 (discussion 42)","journal-title":"Dermatol Surg"},{"key":"4484_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaad.2012.01.010","volume":"67","author":"C Metchnikoff","year":"2012","unstructured":"Metchnikoff\u00a0C, Mully\u00a0T, Singer\u00a0JP et\u00a0al (2012) The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. J\u00a0Am Acad Dermatol 67:829\u2013835. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2012.01.010","journal-title":"J Am Acad Dermatol"},{"key":"4484_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.01.008","author":"SA Mueller","year":"2019","unstructured":"Mueller\u00a0SA, Gauthier M\u2011EA AB et al (2019) Mutational patterns in metastatic cutaneous squamous cell carcinoma. J\u00a0Invest Dermatol. \n                    https:\/\/doi.org\/10.1016\/j.jid.2019.01.008","journal-title":"J Invest Dermatol"},{"key":"4484_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archderm.138.6.758","volume":"138","author":"P Nguyen","year":"2002","unstructured":"Nguyen\u00a0P, Vin-Christian\u00a0K, Ming\u00a0ME, Berger\u00a0T (2002) Aggressive squamous cell carcinomas in persons infected with the human immunodeficiency virus. Arch Dermatol 138:758\u2013763","journal-title":"Arch Dermatol"},{"key":"4484_CR30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40257-019-00426-w","volume":"68","author":"R Patel","year":"2019","unstructured":"Patel\u00a0R, Chang\u00a0ALS (2019) Immune checkpoint inhibitors for treating advanced cutaneous squamous cell carcinoma. Am J Clin Dermatol 68:957\u2013956. \n                    https:\/\/doi.org\/10.1007\/s40257-019-00426-w","journal-title":"Am J Clin Dermatol"},{"key":"4484_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9489163","author":"C Potenza","year":"2018","unstructured":"Potenza\u00a0C, Bernardini\u00a0N, Balduzzi\u00a0V et\u00a0al (2018) A review of the literature of surgical and nonsurgical treatments of invasive squamous cells carcinoma. Biomed Res Int. \n                    https:\/\/doi.org\/10.1155\/2018\/9489163","journal-title":"Biomed Res Int"},{"key":"4484_CR32","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1365-2133.2011.10507.x","volume":"165","author":"S Rangwala","year":"2011","unstructured":"Rangwala\u00a0S, Tsai\u00a0KY (2011) Roles of the immune system in skin cancer. Br J Dermatol 165:953\u2013965. \n                    https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10507.x","journal-title":"Br J Dermatol"},{"key":"4484_CR33","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.18632\/oncotarget.12739","volume":"8","author":"D Ribatti","year":"2017","unstructured":"Ribatti\u00a0D (2017) The concept of immune surveillance against tumors. The first theories. Oncotarget 8:7175\u20137180. \n                    https:\/\/doi.org\/10.18632\/oncotarget.12739","journal-title":"Oncotarget"},{"key":"4484_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2340\/00015555-1501","volume":"93","author":"MH Roozeboom","year":"2013","unstructured":"Roozeboom\u00a0MH, Lohman\u00a0BGPM, Westers-Attema\u00a0A et al (2013) Clinical and histological prognostic factors for local recurrence and metastasis of cutaneous squamous cell carcinoma: analysis of a\u00a0defined population. Acta Derm Venereol 93:417\u2013421. \n                    https:\/\/doi.org\/10.2340\/00015555-1501","journal-title":"Acta Derm Venereol"},{"key":"4484_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1001\/jamadermatol.2017.6428","volume":"154","author":"I Roscher","year":"2018","unstructured":"Roscher\u00a0I, Falk\u00a0RS, Vos\u00a0L et al (2018) Validating 4 staging systems for cutaneous squamous cell carcinoma using population-based data: a nested case-control study. JAMA Dermatol 154:428\u2013434. \n                    https:\/\/doi.org\/10.1001\/jamadermatol.2017.6428","journal-title":"JAMA Dermatol"},{"key":"4484_CR36","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","volume":"26","author":"DE Rowe","year":"1992","unstructured":"Rowe\u00a0DE, Carroll\u00a0RJ, Day\u00a0CL (1992) Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J\u00a0Am Acad Dermatol 26:976\u2013990","journal-title":"J Am Acad Dermatol"},{"key":"4484_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","volume":"149","author":"CD Schmults","year":"2013","unstructured":"Schmults\u00a0CD, Karia\u00a0PS, Carter\u00a0JB et al (2013) Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a\u00a010-year, single-institution cohort study. JAMA Dermatol 149:541\u2013547. \n                    https:\/\/doi.org\/10.1001\/jamadermatol.2013.2139","journal-title":"JAMA Dermatol"},{"key":"4484_CR38","volume-title":"UICC international union against cancer TNM classification of malignant tumors","author":"L Sobin","year":"2009","unstructured":"Sobin\u00a0L, Gospodarowicz\u00a0M, Wittekind\u00a0C (2009) UICC international union against cancer TNM classification of malignant tumors, 7.\u00a0Aufl. Wiley-Blackwell, Hoboken","edition":"7"},{"key":"4484_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-3-642-59410-6_30","volume":"160","author":"E Stockfleth","year":"2002","unstructured":"Stockfleth\u00a0E, Ulrich\u00a0C, Meyer\u00a0T, Christophers\u00a0E (2002) Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 160:251\u2013258","journal-title":"Recent Results Cancer Res"},{"key":"4484_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1046\/j.1365-2133.2000.03519.x","volume":"142","author":"NR Telfer","year":"2000","unstructured":"Telfer\u00a0NR (2000) Mohs\u2019 micrographic surgery for cutaneous squamous cell carcinoma: practical considerations. Br J Dermatol 142:631\u2013633","journal-title":"Br J Dermatol"},{"key":"4484_CR41","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jamadermatol.2015.4994","volume":"152","author":"AK Thompson","year":"2016","unstructured":"Thompson\u00a0AK, Kelley\u00a0BF, Prokop\u00a0LJ et al (2016) Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 152:419\u2013428. \n                    https:\/\/doi.org\/10.1001\/jamadermatol.2015.4994","journal-title":"JAMA Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-04484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-019-04484-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-04484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T23:41:19Z","timestamp":1601077279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-019-04484-3"}},"subtitle":["Wie erkenne ich meinen Hochrisikopatienten?"],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["4484"],"URL":"https:\/\/doi.org\/10.1007\/s00105-019-04484-3","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]},"assertion":[{"value":"27 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0Kofler gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}